An oral complication of bisphosphonate therapy

Sagar Khanna,Brandon Prendes

DOI: https://doi.org/10.1136/bmj-2024-081080

2024-09-13

BMJ

Abstract:During a routine dental examination, a 69 year old man was found to have multiple areas of exposed bone on the lingual aspect of the right mandible (fig 1). He had a history of myeloma and was being treated with lenalidomide and monthly infusions of 4 mg zoledronic acid for chronic pain secondary to multiple spinal compression fractures. He had no known dental disease before starting therapy, or history of trauma or radiation. Computed tomography showed heterogeneous cortical bone destruction suggesting osteonecrosis but no evidence of osteomyelitis or odontogenic infection.bmj;386/sep12_6/e081080/F1F1f1Fig 1Exposed bone in right lingual mandible suggestive of osteonecrosisBony complications of bisphosphonates include osteonecrosis of the jaw and atypical femoral fractures. Patients taking high dose bisphosphonates, in the absence of trauma or radiation, carry a much higher risk of osteonecrosis than the general population.1 Dental evaluation is therefore recommended before starting and during bisphosphonate therapy. This patient's bisphosphonates were stopped,...

medicine, general & internal